References
Andersson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years follow up from the Framingham Study. Journal of the American Medical Association 257: 2176–2180, 1987
Benfante R, Reed D. Is elevated serum cholesterol a risk factor for coronary heart disease in the elderly? Journal of the American Medical Association 263: 393–396, 1990
Carlsson LA, Rosenhamer G. Reduction of mortality in the Stockholm ischaemic disease secondary prevention study by combined treatment with clofibrate and nicotinic acid. Acta Medica Scandinavica 223: 405–418, 1988
Castelli WP, Wilson PW, Levy D, Andersson K. Cardiovascular risk factors in the elderly. American Journal of Cardiology 63: 12H–19H, 1989
Denke MA, Grundy SM. Hypercholesterolemia in elderly persons; resolving the treatment dilemma. Annals of Internal Medicine 112: 780–792, 1990
Expert Panel. Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Archives of Internal Medicine 148: 36–69, 1988
Fagard R. Serum cholesterol levels and survival in the elderly hypertensive patients: analysis of data from European working party on high blood pressure in the elderly. American Journal of Medicine 90(3A): 62–63, 1991
Forette B, Tortrat D, Wolmark Y. Cholesterol as risk factor for mortality in elderly women. Lancet 2: 868–870, 1989
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, et al. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New England Journal of Medicine 317: 1237–1245, 1987
Fries JF, Green LW, Levine S. Health promotion and the compression of morbidity. Lancet 1: 481–483, 1989
Hershcopf RJ, Elahi D, Andres R, Baldwin HL, Raizes GS, et al. Longitudinal changes in serum cholesterol in man: an epidemiologic search for an etiology. Journal of Chronic Diseases 35: 101–114, 1982
Iso H, Jacobs DR, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. New England Journal of Medicine 320: 904–910, 1989
Lehtonen A, Luutonen S. High-density lipoprotein cholesterol levels of very old in the diagnosis of dementia. Age and Ageing 15: 267–270, 1986
Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction of incidence of coronary heart disease. Journal of the American Medical Association 251: 351–364, 1984
Nikkilä M, Heikkinen J. Elevated high-density lipoprotein cholesterol and longevity. Age and Ageing 19: 119–124, 1990
Shipley MJ, Pocock SJ, Marmot MG. Does plasma cholesterol concentration predict mortality from coronary heart disease in elderly people? 18 year follow up in Whitehall study. British Medical Journal 303: 89–92, 1991
Stamler J, Wentworth D, Neaton SD. Is the relationship between serum cholesterol and risk of premature death from coronary disease continuous or graded? Findings in 356,222 primary screens of the multiple risk factor intervention trial (MRFIT). Journal of the American Medical Association 256: 2823–2828, 1986
Study Group, European Atherosclerosis Society. The recognition and management of hyperlipidemia in adults: a policy statement of the European Atherosclerosis Society. European Heart Journal 9: 571–600, 1988
Wallace RB, Colsher PL. Blood lipid and lipoprotein levels in the oldest old: a community-based study. American Heart Association. Abstracts of the 31st Annual Conference on Cardiovascular Disease Epidemiology 18, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tikkanen, M.J., Tilvis, R.S. Hypercholesterolaemia in Aged Patients. Drugs & Aging 1, 427–430 (1991). https://doi.org/10.2165/00002512-199101060-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101060-00002